rs2000959
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004211.5(SLC6A5):c.1738-39C>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.326 in 1,606,736 control chromosomes in the GnomAD database, including 89,865 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.30 ( 7409 hom., cov: 30)
Exomes 𝑓: 0.33 ( 82456 hom. )
Consequence
SLC6A5
NM_004211.5 intron
NM_004211.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -4.07
Publications
13 publications found
Genes affected
SLC6A5 (HGNC:11051): (solute carrier family 6 member 5) This gene encodes a sodium- and chloride-dependent glycine neurotransmitter transporter. This integral membrane glycoprotein is responsible for the clearance of extracellular glycine during glycine-mediated neurotransmission. This protein is found in glycinergic axons and maintains a high presynaptic pool of neurotransmitter at glycinergic synapses. Mutations in this gene cause hyperekplexia; a heterogenous neurological disorder characterized by exaggerated startle responses and neonatal apnea. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2016]
SLC6A5 Gene-Disease associations (from GenCC):
- hyperekplexia 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- hereditary hyperekplexiaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 11-20637133-C-A is Benign according to our data. Variant chr11-20637133-C-A is described in ClinVar as Benign. ClinVar VariationId is 1294497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.48 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| SLC6A5 | NM_004211.5 | c.1738-39C>A | intron_variant | Intron 11 of 15 | ENST00000525748.6 | NP_004202.4 | ||
| SLC6A5 | NM_001318369.2 | c.1036-39C>A | intron_variant | Intron 10 of 14 | NP_001305298.1 | |||
| SLC6A5 | XM_017018544.3 | c.862-39C>A | intron_variant | Intron 7 of 11 | XP_016874033.1 | |||
| SLC6A5 | XR_007062528.1 | n.1116-39C>A | intron_variant | Intron 8 of 13 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| SLC6A5 | ENST00000525748.6 | c.1738-39C>A | intron_variant | Intron 11 of 15 | 1 | NM_004211.5 | ENSP00000434364.2 | |||
| SLC6A5 | ENST00000298923.11 | n.*1035-39C>A | intron_variant | Intron 10 of 14 | 1 | ENSP00000298923.7 | ||||
| SLC6A5 | ENST00000528440.1 | n.269-39C>A | intron_variant | Intron 3 of 7 | 5 |
Frequencies
GnomAD3 genomes AF: 0.299 AC: 45277AN: 151666Hom.: 7389 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
45277
AN:
151666
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.366 AC: 91911AN: 251264 AF XY: 0.369 show subpopulations
GnomAD2 exomes
AF:
AC:
91911
AN:
251264
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.329 AC: 478604AN: 1454954Hom.: 82456 Cov.: 31 AF XY: 0.334 AC XY: 242161AN XY: 724206 show subpopulations
GnomAD4 exome
AF:
AC:
478604
AN:
1454954
Hom.:
Cov.:
31
AF XY:
AC XY:
242161
AN XY:
724206
show subpopulations
African (AFR)
AF:
AC:
5595
AN:
33358
American (AMR)
AF:
AC:
23880
AN:
44686
Ashkenazi Jewish (ASJ)
AF:
AC:
9950
AN:
26068
East Asian (EAS)
AF:
AC:
15088
AN:
39650
South Asian (SAS)
AF:
AC:
42396
AN:
86076
European-Finnish (FIN)
AF:
AC:
17481
AN:
53326
Middle Eastern (MID)
AF:
AC:
1739
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
342692
AN:
1105896
Other (OTH)
AF:
AC:
19783
AN:
60148
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
14152
28304
42457
56609
70761
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
11338
22676
34014
45352
56690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.299 AC: 45310AN: 151782Hom.: 7409 Cov.: 30 AF XY: 0.307 AC XY: 22739AN XY: 74178 show subpopulations
GnomAD4 genome
AF:
AC:
45310
AN:
151782
Hom.:
Cov.:
30
AF XY:
AC XY:
22739
AN XY:
74178
show subpopulations
African (AFR)
AF:
AC:
7294
AN:
41432
American (AMR)
AF:
AC:
6446
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
AC:
1317
AN:
3468
East Asian (EAS)
AF:
AC:
1842
AN:
5138
South Asian (SAS)
AF:
AC:
2364
AN:
4760
European-Finnish (FIN)
AF:
AC:
3496
AN:
10534
Middle Eastern (MID)
AF:
AC:
88
AN:
292
European-Non Finnish (NFE)
AF:
AC:
21505
AN:
67896
Other (OTH)
AF:
AC:
665
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
1496
2992
4487
5983
7479
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
470
940
1410
1880
2350
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1529
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Aug 22, 2019
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Hyperekplexia 3 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.